logo
Mesaj gönder
Shaanxi Hongbaiyi Biotech Co., Ltd.
Shaanxi Hongbaiyi Biotech Co., Ltd.
Ürünler
Evde /

Ürünler

Improve Your Research with Tirzepatide BPC-157 5 mg Thymosin β4 5 mg Blend for Method Validation and Pathway Interrogation

Ürün Detayları

Menşe yeri: Çin

Marka adı: HBY

Sertifika: COA、HLPC、MR

Model numarası: HBY-BPC157+TB-500

Belge: Ürün Broşürü PDF

Ödeme ve Gönderim Koşulları

Min sipariş miktarı: 5 kutu

Fiyat: US$81-82.01/box

Ambalaj bilgileri: 10 mg/şişe, 10 şişe/kutu

Yetenek temini: 30000Boxes/Permonth

En İyi Fiyatı Alın
Şimdi İletişime Geçin
Özellikler
Vurgulamak:
Açıklama
Improve Your Research with Tirzepatide BPC-157 5 mg Thymosin β4 5 mg Blend for Method Validation and Pathway Interrogation

  

 
 
 
 
 
  BPC-157 & TB-500 Blend — 5 mg / 5 mg pairs two well-characterized research peptides—BPC-157 (GEPPPGKPADDAGLV) and Thymosin β4 (TB-500)—to support multi-pathway in-vitro, cellular, and biochemical studies. Supplied by Peptide Tech at ≥99% purity (HPLC/MS verified), this   RUO reference material is ideal for assay development, method validation, and pathway interrogation under controlled laboratory conditions.
 Specifications
 Components BPC-157 (5 mg) + Thymosin β4 / “TB-500” (5 mg)
 CAS Numbers BPC-157: 137525-51-0 · Thymosin β4: 77591-33-4
 PubChem CIDs BPC-157: CID 9941957 · Thymosin β4: CID 16132341
 Molecular Formula (approx.) BPC-157: C62H98N16O22 · Thymosin β4: C212H350N56O78S
 Molecular Weight (approx.) BPC-157: ~1419.5 g/mol · Thymosin β4: ~4963 g/mol
 Sequences BPC-157: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val · Thymosin β4 (43 aa): SDKPDMAEIEKFDKSKLKK TETQEKNPLP SKETIEQEKQ AGES
 Physical Appearance White to off-white lyophilized powder
 Container 3 mL glass vial (blend, 10 mg net content)
 Purity ≥99% (HPLC & MS; third-party verified)
 Solubility Soluble in sterile water or compatible aqueous buffer; mix gently until fully dissolved; 0.22 µm filter-sterilize if required
Sorgunuzu gönderin
Lütfen bize isteğinizi gönderin ve size en kısa sürede cevap vereceğiz.
Göndermek